Hemofarm Executive and Leadership Team

Ronald Seeliger, the Chief Executive Officer at Hemofarm, directs the overarching corporate strategy for the leading pharmaceutical manufacturer in the region. Overseeing the production of over 4 billion tablets and capsules annually, the Chief Executive Officer ensures operational efficiency across all manufacturing facilities. This leadership role involves managing the 17.3% market share within the Serbian pharmaceutical sector while driving expansion initiatives across broader European markets. By aligning internal resources with the company mission of health commitment, Ronald Seeliger optimizes the organizational structure to support sustainable growth. The Chief Executive Officer maintains constant communication with the Board to refine long-term objectives and secure the company's position as the primary exporter of medicinal products. Through rigorous oversight of manufacturing standards and quality control, Seeliger guarantees that all pharmaceutical outputs meet international regulatory requirements, thereby reinforcing the reputation of the firm as a reliable provider of essential healthcare solutions.

Dr. Seeliger, the President & Chief Executive Officer, Stada Balkan Cluster & Hemofarm at Hemofarm, manages the integration of regional pharmaceutical operations across the Balkan cluster. Coordinating complex cross-border logistics, the President & Chief Executive Officer, Stada Balkan Cluster & Hemofarm ensures that the 79.1% export share remains stable while identifying new growth opportunities in emerging markets. This executive role requires balancing the needs of the Stada group with the specific requirements of the local manufacturing base. By streamlining regional supply chains, Dr. Seeliger enhances the competitive advantage of the company in a crowded pharmaceutical landscape. The President & Chief Executive Officer, Stada Balkan Cluster & Hemofarm drives strategic partnerships that facilitate the distribution of medicinal products to diverse patient populations. Through consistent focus on regional market dynamics, Seeliger secures the financial health of the cluster while upholding the core commitment to patient well-being and high-quality pharmaceutical manufacturing standards.

Vidosava Aleksic, the Chief Financial Officer, Pomocnik at Hemofarm, manages the fiscal health and capital allocation for the leading pharmaceutical entity in the region. Overseeing the financial reporting and budgeting processes, the Chief Financial Officer, Pomocnik ensures that the 17.3% market share translates into sustainable profitability. This leadership role involves monitoring the costs associated with the massive production of tablets and capsules to maintain competitive pricing. By optimizing the financial structure, Vidosava Aleksic supports the investment in new manufacturing technologies and export infrastructure. The Chief Financial Officer, Pomocnik works closely with the executive team to evaluate the financial impact of regional expansion projects and long-term strategic initiatives. Through rigorous risk management and financial planning, Aleksic secures the resources necessary to uphold the company's commitment to health. The Chief Financial Officer, Pomocnik provides the transparency and fiscal discipline required to maintain investor confidence and support the ongoing growth of the pharmaceutical operations.

Tijana Marković, the Chief Marketing Officer, Fmd & Specialist at Hemofarm, architects the commercial strategy for specialized pharmaceutical products and FMD compliance. Overseeing the promotion of the extensive product portfolio, the Chief Marketing Officer, Fmd & Specialist ensures that healthcare providers receive accurate information regarding the efficacy of the 4 billion units produced annually. This leadership role involves analyzing market trends to position the company as the preferred partner for specialized medical treatments. By executing targeted campaigns, Tijana Marković increases brand visibility and strengthens the market share in the competitive Serbian pharmaceutical landscape. The Chief Marketing Officer, Fmd & Specialist collaborates with the sales teams to align promotional activities with the broader corporate mission of health improvement. Through the implementation of advanced marketing analytics, Marković identifies new segments for growth, ensuring that the company remains at the forefront of the regional pharmaceutical industry while maintaining strict adherence to all regulatory marketing guidelines.

Danijela Viciknez, the Regional Chief Marketing Officer, Head Supply Network at Hemofarm, directs the complex logistics and supply chain operations that support the company's status as a leading exporter. Overseeing the distribution network, the Regional Chief Marketing Officer, Head Supply Network ensures that medicinal products reach regional markets with maximum efficiency. This leadership role involves coordinating with manufacturing units to align production schedules with the high demand for tablets and capsules. By optimizing the supply chain, Danijela Viciknez reduces lead times and enhances the reliability of the export operations. The Regional Chief Marketing Officer, Head Supply Network integrates marketing insights into supply chain planning to ensure that product availability matches regional market needs. Through the management of the supply network, Viciknez supports the company's mission of providing essential health products across the region. The Regional Chief Marketing Officer, Head Supply Network drives operational excellence by streamlining the flow of goods from the production floor to the final point of care.